KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre study

A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets

(2012) Niantao Deng et al.   GUT

Relevance of MET activation and genetic alterations of KRAS and E-cadherin for cetuximab sensitivity of gastric cancer cell lines

(2012) Stefan Heindl et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

KRAS and BRAF Mutation Analysis in Routine Molecular Diagnostics

(2012) Daniëlle A.M. Heideman et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Gastric cancers of Western European and African patients show different patterns of genomic instability

(2011) Tineke E Buffart et al.   BMC Medical Genomics

In vitro and in vivo antitumor activity of cetuximab in human gastric cancer cell lines in relation to epidermal growth factor receptor (EGFR) expression and mutational phenotype

(2011) Birgit Hotz et al.   Gastric Cancer

Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer

(2011) Gordon Hutchins et al.   JOURNAL OF CLINICAL ONCOLOGY

Targeting the human EGFR family in esophagogastric cancer

(2011) Alicia Okines et al.   Nature Reviews Clinical Oncology

Oncogenic mutations in gastric cancer with microsatellite instability

(2010) Giovanni Corso et al.   EUROPEAN JOURNAL OF CANCER

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

KRASandBRAFMutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial

(2009) Susan D. Richman et al.   JOURNAL OF CLINICAL ONCOLOGY